Adaptive Biotechnologies ADPT Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$49.64M+65.0% | -$59.46M+62.7% | -$79.6M+59.3% | -$121.24M+43.2% | -$141.89M+34.0% | ||
| $15.24M-10.7% | $16.13M-8.1% | $16.39M-11.4% | $16.57M-15.7% | $17.07M-16.0% | ||
| $51.26M-0.4% | $51.48M-4.0% | $51.6M-8.4% | $51.86M-10.8% | $51.46M-17.7% | ||
| -$29.09M+65.9% | -$48.04M+49.5% | -$60.53M+44.8% | -$80.47M+37.8% | -$85.34M+37.0% | ||
| $2.5M-26.8% | $2.96M-19.2% | $2.4M-50.8% | $2.34M-68.0% | $3.41M-63.2% | ||
| —— | —— | $68.32M+16.0% | $56.33M-29.4% | $58.86M-47.1% | ||
| $32.45M+475% | $30.4M+12,515% | $8.87M+4,314% | $7.23M+3,961% | $5.65M+249% | ||
| $26.93M— | $22.37M— | —— | —— | —— | ||
| -$30.95M+65.1% | -$50.36M+49.1% | -$62.94M+45.1% | -$82.81M+39.4% | -$88.76M+38.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Adaptive Biotechnologies generate?
- Adaptive Biotechnologies (ADPT) generated -$29.1M in operating cash flow over the trailing twelve months.
- What is Adaptive Biotechnologies's free cash flow?
- After $2.5M of capital expenditures, Adaptive Biotechnologies's free cash flow was -$31.0M over the trailing twelve months, up 65.1% year over year.
- Where does Adaptive Biotechnologies's cash flow data come from?
- Every line is extracted from Adaptive Biotechnologies's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
